Arbutus Medical Inc.
PrivateLast Round
Growth Equity
Feb 17, 2026
Total Funding Raised
$12.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arbutus Medical Inc. operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Growth Equity round in February 2026.
Arbutus Medical Inc. is a medical devices and equipment company that develops and manufactures affordable orthopedic power tools and sterile-packed procedure kits designed to improve surgical access and efficiency.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arbutus Medical Inc. Comparables
Compare Arbutus Medical Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zimmer Biomet | 68% | |
| CONMED Corporation | 68% | |
| Johnson & Johnson | 64% |
For institutional investors. Book with your work email.
Arbutus Medical Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 17, 2026 | ||||
| VC Round | Feb 13, 2023 | ||||
| Grant | Jul 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arbutus Medical Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genome British Columbia | Growth Equity, VC Round |
| Nimbus Synergies | Growth Equity, Seed, VC Round |
| MEDTEQ+ | Growth Equity, VC Round |
| Grand Challenges Canada | Grant |
| ScaleGood Fund | VC Round |
| ThresholdImpact | Growth Equity, VC Round |
| Crédit Mutuel Equity | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 19, representing 51% of headcount.
- Jul 20, 2026
Open roles increased to 17, 46% of headcount.
For institutional investors. Book with your work email.
Arbutus Medical Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arbutus Medical Inc.'s valuation, stock price, and market status.
Is Arbutus Medical Inc. a public or private company?
Arbutus Medical Inc. is a private company.
What is the current stock price of Arbutus Medical Inc.?
Arbutus Medical Inc. is a private company, so its shares have no public market price. Caplight tracks Arbutus Medical Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arbutus Medical Inc. worth (valuation)?
Valuation information for Arbutus Medical Inc. is not publicly available.
Can I buy Arbutus Medical Inc. stock?
Arbutus Medical Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arbutus Medical Inc.'s last funding round?
Arbutus Medical Inc.'s most recent funding round was Growth Equity on February 17, 2026.
Who are the main investors in Arbutus Medical Inc.?
Key investors in Arbutus Medical Inc. include Genome British Columbia, Nimbus Synergies, Crédit Mutuel Equity.
Will Arbutus Medical Inc. IPO soon?
No public IPO plans have been announced for Arbutus Medical Inc..
How can I track Arbutus Medical Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Arbutus Medical Inc.'s shares on secondary markets.